The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed Amendment No. 2 to a Schedule 13G with the SEC on November 9, 2026, disclosing their beneficial ownership of Class A Common Stock in Definitive Healthcare Corp as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: Both reporting persons each reported 1,038,392 shares of Definitive Healthcare Corp Class A Common Stock beneficially owned.
  • Percent of class: The reported holdings represent 1.0% of the outstanding class, according to the filing.
  • Shared voting power: Each reporting person disclosed shared voting power over 1,037,661 shares, with zero sole voting power.
  • Shared dispositive power: Each reporting person disclosed shared dispositive power over 1,038,392 shares, with zero sole dispositive power.
  • Event date: The date of the event requiring the filing was September 30, 2026.
  • Joint filers: The Goldman Sachs Group, Inc. (Delaware) and Goldman Sachs & Co. LLC (New York) filed jointly, signed by attorney-in-fact Ameen Soetan on October 8, 2026.

Goldman Sachs Discloses Passive Stake in Definitive Healthcare as of September 30, 2026

According to the filing, The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC each reported aggregate beneficial ownership of 1,038,392 shares of Definitive Healthcare Corp's Class A Common Stock, par value $0.001 per share (CUSIP 24477E103). The filing identifies this as Amendment No. 2 to a Schedule 13G, triggered by an event dated September 30, 2026, and was submitted on November 9, 2026. The issuer, Definitive Healthcare Corp, is headquartered at 492 Old Connecticut Path, Suite 401, Framingham, Massachusetts 01701, according to the filing.

The filing discloses that neither reporting person holds sole voting or sole dispositive power over any shares. Instead, shared voting power is reported at 1,037,661 shares and shared dispositive power at 1,038,392 shares for each entity. The Goldman Sachs Group, Inc. is identified as a parent holding company incorporated in Delaware, while Goldman Sachs & Co. LLC is classified as a broker-dealer, other organization, and investment adviser organized in New York. The filing states that Goldman Sachs & Co. LLC is a subsidiary of The Goldman Sachs Group, Inc.

The filing includes certifications, as required, stating that "the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." Exhibit 99.3 notes that the filing "reflects the securities beneficially owned by certain operating units (collectively, the 'Goldman Sachs Reporting Units')" and that those units "disclaim beneficial ownership" of securities held in certain client accounts and investment entities, in accordance with SEC Release No. 34-39538 (January 12, 1998).

What Was Disclosed

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC jointly filed Amendment No. 2 to Schedule 13G, reporting combined beneficial ownership of 1,038,392 shares, or 1.0%, of Definitive Healthcare Corp's Class A Common Stock as of September 30, 2026.